Medical Arts Health Research Group

Penticton, British Columbia V2A 5C8

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Chronic Idiopathic Constipation

Studies at this site

• Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early
• Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed